{"id":147693,"date":"2024-12-19T20:00:17","date_gmt":"2024-12-19T14:30:17","guid":{"rendered":"https:\/\/pwonlyias.com\/stage\/?post_type=editorial-analysis&#038;p=147693"},"modified":"2024-12-19T20:00:17","modified_gmt":"2024-12-19T14:30:17","slug":"making-affordable-generics-more-reliable","status":"publish","type":"editorial-analysis","link":"https:\/\/pwonlyias.com\/stage\/editorial-analysis\/making-affordable-generics-more-reliable","title":{"rendered":"Making Affordable Generics More Reliable"},"content":{"rendered":"<p><span style=\"font-weight: 400;\">Generic drugs are vital for improving healthcare affordability in India, addressing significant income disparities. However, maintaining their quality and efficacy remains a critical challenge.<\/span><\/p>\n<h2><span style=\"font-size: 18pt;\"><b>Basics of Generic Drugs<\/b><\/span><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">When a new drug is developed, it is protected by a <\/span><b>20-year patent<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">This allows the innovator company to recover its <\/span><b>research and development (R&#038;D) costs<\/b><span style=\"font-weight: 400;\"> through exclusive sales during the patent period.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Generic drugs are <\/span><b>bioequivalent<\/b><span style=\"font-weight: 400;\"> to branded or innovator drugs, meaning they have the same <\/span><b>active ingredients<\/b><span style=\"font-weight: 400;\">, <\/span><b>dosage form<\/b><span style=\"font-weight: 400;\">, <\/span><b>strength<\/b><span style=\"font-weight: 400;\">, and <\/span><b>route of administration<\/b><span style=\"font-weight: 400;\"> as the original.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Generics are sold under their <\/span><b>chemical name<\/b><span style=\"font-weight: 400;\"> rather than a brand name.<\/span><\/li>\n<\/ul>\n<p style=\"text-align: center;\"><span class=\"vc_button\"><a href=\"https:\/\/www.pw.live\/batches\/upsc?utm_source=seo+upsc+batch&#038;utm_medium=seo+upsc&#038;utm_campaign=seo&#038;utm_id=upsc\" target=\"_blank\" rel=\"noopener\">Enroll now for UPSC Online Course<\/a><\/span><\/p>\n<h2><span style=\"font-size: 18pt;\"><b>Key Differences Between Generics and Branded Drugs<\/b><\/span><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Generic drugs may use<\/span><b> different binders (to hold ingredients together) and fillers (to add bulk or improve stability).<\/b><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Generic manufacturers do not bear the high expenses associated with new drug development or extensive clinical trials, making generics significantly cheaper.<\/span><\/li>\n<\/ul>\n<h2><span style=\"font-size: 18pt;\"><b>Impact of Generic Drugs<\/b><\/span><\/h2>\n<ul>\n<li><span style=\"font-weight: 400;\">The lower cost of generics makes them more accessible, ensuring <\/span><b>affordable healthcare<\/b><span style=\"font-weight: 400;\"> for patients.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span>\n<ul>\n<li><span style=\"font-weight: 400;\">By August 2024, generic medicines worth \u20b95,600 crore sold through Pradhan Mantri Bhartiya Janaushadhi Pariyojana over a decade saved consumers an estimated \u20b930,000 crore.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span><\/li>\n<\/ul>\n<\/li>\n<li><span style=\"font-weight: 400;\">By offering cost-effective alternatives, generics play a crucial role in improving <\/span><b>treatment adherence<\/b><span style=\"font-weight: 400;\"> and reducing <\/span><b>healthcare expenditure<\/b><span style=\"font-weight: 400;\">.\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400;\">With out-of-pocket healthcare expenditure at <\/span><b>39.4% of total health expenditure in 2021-22<\/b><span style=\"font-weight: 400;\">, generics reduce financial burdens and improve treatment adherence.\u00a0<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h2><span style=\"font-size: 18pt;\"><b>Challenges Associated with Generic Medicines\u00a0\u00a0<\/b><\/span><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Quality Control Lapses:<\/b><span style=\"font-weight: 400;\"> Although generics are meant to be bioequivalent to branded drugs, there are instances where the quality doesn&#8217;t meet the expected standards, leading to concerns about their safety and efficacy.<\/span>\n<ul>\n<li><span style=\"font-weight: 400;\">A study by doctors from PGIMER, Chandigarh, highlighted this issue.\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400;\">When treating <\/span><b>chronic pulmonary aspergillosis<\/b><span style=\"font-weight: 400;\"> with the antifungal drug <\/span><b>itraconazole<\/b><span style=\"font-weight: 400;\">, the innovator (branded) drug achieved therapeutic drug levels in <\/span><b>73%<\/b><span style=\"font-weight: 400;\"> of patients within <\/span><b>two weeks<\/b><span style=\"font-weight: 400;\">.\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400;\">In contrast, generics reached the same therapeutic levels in only <\/span><b>29%<\/b><span style=\"font-weight: 400;\"> of patients, often requiring <\/span><b>longer treatment durations<\/b><span style=\"font-weight: 400;\"> or <\/span><b>higher doses<\/b><span style=\"font-weight: 400;\"> to achieve similar outcomes.\u00a0<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<h2><span style=\"font-size: 18pt;\"><b>Reasons for Generic Drug Variability<\/b><\/span><\/h2>\n<ul>\n<li aria-level=\"1\"><b>Differences in Excipients: <\/b><span style=\"font-weight: 400;\">Variations in excipients\u2014such as <\/span><b>binders<\/b><span style=\"font-weight: 400;\">, <\/span><b>fillers<\/b><span style=\"font-weight: 400;\">, <\/span><b>disintegrants<\/b><span style=\"font-weight: 400;\">, and <\/span><b>coatings<\/b><span style=\"font-weight: 400;\">\u2014can significantly alter a drug&#8217;s <\/span><b>dissolution rate<\/b><span style=\"font-weight: 400;\">, <\/span><b>stability<\/b><span style=\"font-weight: 400;\">, and <\/span><b>delivery mechanism<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<li><b>Variations in Manufacturing Processes: <\/b><span style=\"font-weight: 400;\">Differences in manufacturing processes, including the <\/span><b>type of punching machines<\/b><span style=\"font-weight: 400;\">, <\/span><b>compression force<\/b><span style=\"font-weight: 400;\">, and <\/span><b>granulation methods<\/b><span style=\"font-weight: 400;\">, can influence the drug\u2019s <\/span><b>physical<\/b><span style=\"font-weight: 400;\"> and <\/span><b>chemical properties<\/b><span style=\"font-weight: 400;\">.<\/span>\n<ul>\n<li><span style=\"font-weight: 400;\">Variations in <\/span><b>tablet hardness<\/b><span style=\"font-weight: 400;\">, <\/span><b>particle size<\/b><span style=\"font-weight: 400;\">, <\/span><b>porosity<\/b><span style=\"font-weight: 400;\"> can affect the drug\u2019s <\/span><b>disintegration<\/b><span style=\"font-weight: 400;\"> and <\/span><b>absorption<\/b><span style=\"font-weight: 400;\"> in the bloodstream.\u00a0<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p style=\"text-align: center;\"><span class=\"vc_button\"><a href=\"https:\/\/store.pw.live\/govt-entrance-exams\/upsc-books?utm_source=SEO&#038;utm_medium=PW+Live&#038;utm_campaign=UPSC+CSE+Books\" target=\"_blank\" rel=\"noopener\"><span style=\"font-weight: 400;\">Check Out UPSC CSE Books From PW Store<\/span><\/a><\/span><\/p>\n<div class=\"vc_table_green\"><\/p>\n<table style=\"width: 99.5971%;\">\n<tbody>\n<tr>\n<th style=\"width: 100%; border-style: solid; border-color: #000000; background-color: rgba(184, 165, 217, 0.53); text-align: left; vertical-align: middle;\"><span style=\"color: #000000;\"><span style=\"font-weight: 400;\">Generic medications often use <\/span><b>pellets<\/b><span style=\"font-weight: 400;\"> (small particles) inside capsules or tablets to control the release and absorption of the <\/span><b>active pharmaceutical ingredient (API)<\/b><span style=\"font-weight: 400;\">. If the pellets are not uniform in size, they may dissolve at different rates, leading to inconsistent drug absorption.\u00a0<\/span><\/span><\/th>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div>\n<ul>\n<li style=\"list-style-type: none;\">\n<ul>\n<li><span style=\"font-weight: 400;\">In some cases, while innovator drugs are designed to release the active pharmaceutical ingredient (API) slowly to provide a sustained therapeutic effect, generics may release the API more rapidly, which could lead to <\/span><b>fluctuations in drug levels<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<\/ul>\n<\/li>\n<li><b>Bioequivalence Threshold Limitations: <\/b><span style=\"font-weight: 400;\">Regulatory standards often allow pharmacokinetic parameters to fall within an <\/span><b>80%-125%<\/b><span style=\"font-weight: 400;\"> range of the innovator drug\u2019s performance.\u00a0<\/span>\n<ul>\n<li><span style=\"font-weight: 400;\">These thresholds may not be sufficient for drugs with a <\/span><b>narrow therapeutic index<\/b><span style=\"font-weight: 400;\">.\u00a0<\/span><\/li>\n<li><span style=\"font-weight: 400;\">Even minor deviations in drug release or bioavailability can result in <\/span><b>subtherapeutic effects<\/b><span style=\"font-weight: 400;\"> or <\/span><b>adverse reactions<\/b><span style=\"font-weight: 400;\">.<\/span><\/li>\n<\/ul>\n<\/li>\n<li aria-level=\"1\"><b>Issues with Testing and Drug Formulation : <\/b><span style=\"font-weight: 400;\">Inconsistent stability testing and variations in drug formulation can undermine the <\/span><b>shelf life<\/b><span style=\"font-weight: 400;\"> and <\/span><b>reliability<\/b><span style=\"font-weight: 400;\"> of generic drugs, further contributing to variability in their performance and effectiveness.<\/span><\/li>\n<\/ul>\n<h2><span style=\"font-size: 18pt;\"><b>Key Issues in India&#8217;s Drug Regulation System<\/b><\/span><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Decentralised Drug Regulation: <\/b><span style=\"font-weight: 400;\">India\u2019s decentralised regulatory system grants significant authority to <\/span><b>State Drug Regulatory Authorities (SDRAs),<\/b><span style=\"font-weight: 400;\"> leading to:<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><b>Inconsistent enforcement:<\/b><span style=\"font-weight: 400;\"> Variability in quality standards.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><b>Regulatory arbitrage:<\/b><span style=\"font-weight: 400;\"> Manufacturers exploit weaker oversight in certain states.<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Inadequate Stability Testing: <\/b><span style=\"font-weight: 400;\">Stability testing ensures that drugs maintain their quality under diverse climatic conditions.\u00a0<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Mandated by the <\/span><b>Central Drugs Standard Control Organisation (CDSCO)<\/b><span style=\"font-weight: 400;\"> in 2018, inconsistent implementation and lack of retrospective applicability to pre-2018 generics perpetuate the presence of substandard drugs.<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Permissive Drug Impurity Standards: <\/b><span style=\"font-weight: 400;\">India\u2019s pharmacopoeia permits higher impurity levels compared to U.S. and EU standards.\u00a0<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">The rejection of stricter <\/span><b>ICH guidelines<\/b><span style=\"font-weight: 400;\"> as \u201ctoo expensive\u201d compromises the overall quality of generic drugs.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<div class=\"vc_table_green\"><\/p>\n<table style=\"width: 99.498%;\">\n<tbody>\n<tr>\n<th style=\"width: 100%; border-style: solid; border-color: #000000; background-color: rgba(184, 165, 217, 0.53); text-align: left; vertical-align: middle;\"><span style=\"color: #000000;\"><b>ICH Guidelines<\/b><\/span><\/p>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000;\">The International Council for Harmonisation (ICH) develops guidelines to harmonize the technical requirements for pharmaceutical product registration across regions.\u00a0<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><span style=\"font-weight: 400; color: #000000;\">These guidelines ensure that safe, effective, and high-quality medicines are developed and registered efficiently, facilitating global drug approval processes and reducing duplication of testing.<\/span><\/li>\n<\/ul>\n<\/th>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div>\n<h2><span style=\"font-size: 18pt;\"><b>Way Forward<\/b><\/span><\/h2>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Centralisation of Drug Regulation<\/b><span style=\"font-weight: 400;\">:<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">States should <\/span><b>relinquish control<\/b><span style=\"font-weight: 400;\"> over drug regulation, transferring this responsibility to the <\/span><b>CDSCO<\/b><span style=\"font-weight: 400;\"> for uniform enforcement of quality standards across the country.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">The <\/span><b>Bhatia (1954)<\/b><span style=\"font-weight: 400;\">, <\/span><b>Hathi (1975)<\/b><span style=\"font-weight: 400;\">, and <\/span><b>Mashelkar (2003)<\/b><span style=\"font-weight: 400;\"> committees have long advocated for <\/span><b>centralisation<\/b><span style=\"font-weight: 400;\">, and their recommendations must be implemented without delay.<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Strengthening the CDSCO<\/b><span style=\"font-weight: 400;\">:<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><b>Increase personnel, funding, and infrastructure<\/b><span style=\"font-weight: 400;\"> to improve regulatory oversight.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Establish <\/span><b>more centralised drug-testing laboratories<\/b><span style=\"font-weight: 400;\"> to ensure consistent and reliable quality checks for all generics across the country.<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Enhanced Stability Testing<\/b><span style=\"font-weight: 400;\">:<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><b>Mandate periodic reassessment<\/b><span style=\"font-weight: 400;\"> of all approved generics, including those cleared before 2018, to ensure they meet modern stability testing standards.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><b>Enforce uniform stability testing protocols<\/b><span style=\"font-weight: 400;\"> across states to prevent quality issues and ensure the drugs remain effective throughout their shelf life.<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Stricter Impurity Standards<\/b><span style=\"font-weight: 400;\">:<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Align India\u2019s <\/span><b>impurity limits<\/b><span style=\"font-weight: 400;\"> with international standards by adopting stricter <\/span><b>ICH (International Council for Harmonisation)<\/b><span style=\"font-weight: 400;\"> guidelines.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">This would help improve the <\/span><b>safety<\/b><span style=\"font-weight: 400;\"> and <\/span><b>efficacy<\/b><span style=\"font-weight: 400;\"> of generics, ensuring they meet global quality expectations.<\/span><\/li>\n<\/ul>\n<\/li>\n<li style=\"font-weight: 400;\" aria-level=\"1\"><b>Overhaul Regulatory Thresholds<\/b><span style=\"font-weight: 400;\">:<\/span>\n<ul>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">Revise <\/span><b>bioequivalence thresholds<\/b><span style=\"font-weight: 400;\"> for drugs with a <\/span><b>narrow therapeutic index<\/b><span style=\"font-weight: 400;\"> (NTI) to ensure stricter control.<\/span><\/li>\n<li style=\"font-weight: 400;\" aria-level=\"2\"><span style=\"font-weight: 400;\">This would ensure tighter parameters for critical medications, preventing minor deviations from affecting therapeutic outcomes or causing adverse reactions.<\/span><\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<p style=\"text-align: center;\"><span class=\"vc_button\"><a href=\"https:\/\/www.pw.live\/batches\/upsc\/pw-only-ias?utm_source=seo+upsc+batch&#038;utm_medium=seo+upsc&#038;utm_campaign=seo&#038;utm_id=upsc\" target=\"_blank\" rel=\"noopener\">Enroll now for UPSC Online Classes<\/a><\/span><\/p>\n<h2><span style=\"font-size: 18pt;\"><b>Conclusion<\/b><\/span><\/h2>\n<p><span style=\"font-weight: 400;\">Generic medicines are indispensable for equitable access to healthcare in India. However, their effectiveness must match affordability to sustain public trust.<\/span><\/p>\n<table style=\"width: 99.5984%;\">\n<tbody>\n<tr>\n<th style=\"width: 100%; border-style: solid; border-color: #000000; background-color: rgba(184, 165, 217, 0.53); text-align: left; vertical-align: middle;\"><span style=\"color: #000000;\"><b>Mains Question:<\/b><\/span><\/p>\n<p><span style=\"font-weight: 400; color: #000000;\"><a style=\"color: #000000;\" href=\"https:\/\/pwonlyias.com\/stage\/mains-answer-writing\/the-interplay-between-affordability-and-quality-in-indias-generic-pharmaceutical\/\" target=\"_blank\" rel=\"noopener\">Q. Critically examine the interplay between affordability and quality in India&#8217;s generic pharmaceutical landscape. Highlight the challenges posed by decentralized drug regulations, variations in manufacturing standards, and non-uniform enforcement mechanisms. (15 M, 250 words)<\/a>\u00a0<\/span><\/th>\n<\/tr>\n<\/tbody>\n<\/table>\n<div class=\"vc_table_green\"><\/p>\n<table style=\"width: 99.6375%;\">\n<tbody>\n<tr>\n<td style=\"width: 111.19%; text-align: center;\" colspan=\"2\"><span style=\"font-size: 18pt;\"><b>Also Read<\/b><\/span><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.797%; text-align: center;\"><a href=\"https:\/\/pwonlyias.com\/stage\/editorial-analysis\/\" target=\"_blank\" rel=\"noopener\"><b>UPSC Daily Editorials<\/b><\/a><\/td>\n<td style=\"width: 61.393%; text-align: center;\"><a href=\"https:\/\/pwonlyias.com\/stage\/daily-current-affairs\/\" target=\"_blank\" rel=\"noopener\"><b>UPSC Daily Current Affairs<\/b><\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.797%; text-align: center;\"><a href=\"https:\/\/pwonlyias.com\/stage\/quiz\/\" target=\"_blank\" rel=\"noopener\"><b>Daily Current Affairs Quiz<\/b><\/a><\/td>\n<td style=\"width: 61.393%; text-align: center;\"><a href=\"https:\/\/pwonlyias.com\/stage\/mains-answer-writing\/\" target=\"_blank\" rel=\"noopener\"><b>Daily Main Answer Writing<\/b><\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.797%; text-align: center;\"><a href=\"https:\/\/store.pw.live\/govt-entrance-exams\/upsc-books\/upsc-previous-year-papers?utm_source=SEO&#038;utm_medium=PW+Live&#038;utm_campaign=UPSC+Previous+Year+Papers\" target=\"_blank\" rel=\"noopener\"><b>Check Out Previous Years Papers From PW Store<\/b><\/a><\/td>\n<td style=\"width: 61.393%; text-align: center;\"><a href=\"https:\/\/pwonlyias.com\/stage\/upsc-test-series-courses\/\" target=\"_blank\" rel=\"noopener\"><b>UPSC Test Series<\/b><\/a><\/td>\n<\/tr>\n<tr>\n<td style=\"width: 49.797%; text-align: center;\"><a href=\"https:\/\/store.pw.live\/govt-entrance-exams\/upsc-books\/upsc-textbooks?utm_source=SEO&#038;utm_medium=PW+Live&#038;utm_campaign=UPSC+Textbooks\" target=\"_blank\" rel=\"noopener\"><b>Check Out UPSC NCERT Textbooks From PW Store<\/b><\/a><\/td>\n<td style=\"width: 61.393%; text-align: center;\"><a href=\"https:\/\/store.pw.live\/govt-entrance-exams\/upsc-books\/upsc-modules?utm_source=SEO&#038;utm_medium=PW+Live&#038;utm_campaign=UPSC+Modules\" target=\"_blank\" rel=\"noopener\"><b>Check Out UPSC Modules From PW Store<\/b><\/a><b>\u00a0<\/b><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><\/div>\n","protected":false},"excerpt":{"rendered":"<p>Generic drugs are vital for improving healthcare affordability in India, addressing significant income disparities. However, maintaining their quality and efficacy remains a critical challenge.<\/p>\n","protected":false},"author":11,"featured_media":147658,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","format":"standard","meta":{"rank_math_lock_modified_date":false,"footnotes":""},"tags":[],"paper-wise":[2084],"subject":[],"acf":[],"_links":{"self":[{"href":"https:\/\/pwonlyias.com\/stage\/wp-json\/wp\/v2\/editorial-analysis\/147693"}],"collection":[{"href":"https:\/\/pwonlyias.com\/stage\/wp-json\/wp\/v2\/editorial-analysis"}],"about":[{"href":"https:\/\/pwonlyias.com\/stage\/wp-json\/wp\/v2\/types\/editorial-analysis"}],"author":[{"embeddable":true,"href":"https:\/\/pwonlyias.com\/stage\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/pwonlyias.com\/stage\/wp-json\/wp\/v2\/comments?post=147693"}],"version-history":[{"count":2,"href":"https:\/\/pwonlyias.com\/stage\/wp-json\/wp\/v2\/editorial-analysis\/147693\/revisions"}],"predecessor-version":[{"id":147695,"href":"https:\/\/pwonlyias.com\/stage\/wp-json\/wp\/v2\/editorial-analysis\/147693\/revisions\/147695"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pwonlyias.com\/stage\/wp-json\/wp\/v2\/media\/147658"}],"wp:attachment":[{"href":"https:\/\/pwonlyias.com\/stage\/wp-json\/wp\/v2\/media?parent=147693"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pwonlyias.com\/stage\/wp-json\/wp\/v2\/tags?post=147693"},{"taxonomy":"paper-wise","embeddable":true,"href":"https:\/\/pwonlyias.com\/stage\/wp-json\/wp\/v2\/paper-wise?post=147693"},{"taxonomy":"subject","embeddable":true,"href":"https:\/\/pwonlyias.com\/stage\/wp-json\/wp\/v2\/subject?post=147693"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}